REQUEST A DEMO
Total
USD $0.00
Search more companies

Biopreparat AO (Биопрепарат АО) (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Biopreparat AO Profile Updated: October 17, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Biopreparat AO (Биопрепарат АО) is based in Russia, with the head office in Moscow. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on August 01, 2002. In 2025, the company reported a net sales revenue increase of 220.45%. Its’ total assets recorded a negative growth of 9.28%. In 2025, Biopreparat AO (Биопрепарат АО)’s net profit margin decreased by 0.08%.

Headquarters
Klary Cetkin, 4, 25,25A,26,27,27A,27B,27V,51/2
Moscow; Moscow; Postal Code: 127299

Contact Details: Purchase the Biopreparat AO (Биопрепарат АО) report to view the information.

Basic Information
Registered Capital:
Purchase the Biopreparat AO (Биопрепарат АО) report to view the information.
Financial Auditors:
Purchase the Biopreparat AO (Биопрепарат АО) report to view the information.
Incorporation Date:
August 01, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Himbiosintez OAO
100%
Ibp OOO
70%
Biokras OOO
52%
Company Performance
Financial values in the chart are available after Biopreparat AO (Биопрепарат АО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
220.45%▲
Total Operating Revenue
220.45%▲
Operating Profit
-41.93%▼
Net Profit/Loss for the Period
170.31%▲
Total Assets
-9.28%▼
Total Equity
26.15%▲
Operating Profit Margin
9.35%▲
Net Profit Margin
-0.08%▼
Return on Equity (ROE)
11.05%▲
Quick Ratio
0.24%▲
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?